Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

UCB Pharma AB (Sweden)

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 21,039 Less Arrow 19,001 More Arrow 19,531
Financial expenses 64 Less Arrow 44 Less Arrow 14
Earnings before taxes 1,099 Less Arrow 914 More Arrow 961
EBITDA 1,098 Less Arrow 943 More Arrow 971
Total assets 15,146 Less Arrow 11,874 Less Arrow 11,269
Current assets 15,146 Less Arrow 11,874 Less Arrow 11,269
Current liabilities 9,429 Less Arrow 6,341 Less Arrow 5,254
Equity capital 5,717 Less Arrow 5,533 More Arrow 6,016
- share capital 9 Equal arrow 9 More Arrow 10
Employees (average) 35 Less Arrow 30 More Arrow 31

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 37.7% More Arrow 46.6% More Arrow 53.4%
Turnover per employee 601 More Arrow 633 Less Arrow 630
Profit as a percentage of turnover 5.2% Less Arrow 4.8% More Arrow 4.9%
Return on assets (ROA) 7.7% More Arrow 8.1% More Arrow 8.7%
Current ratio 160.6% More Arrow 187.3% More Arrow 214.5%
Return on equity (ROE) 19.2% Less Arrow 16.5% Less Arrow 16.0%
Change turnover 1,983 Less Arrow 1,052 Less Arrow 963
Change turnover % 10% Less Arrow 6% Less Arrow 5%
Chg. No. of employees 5 Less Arrow -1 More Arrow 5
Chg. No. of employees % 17% Less Arrow -3% More Arrow 19%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.